GHK Peptide Guide (2026)
Complete Guide & Evidence (2026)
GHK (glycyl-L-histidyl-L-lysine) is the base tripeptide before copper binding. Activates wound healing genes, collagen synthesis.
GHK Multi-System Mechanism
Key Research Data
Proportion of aging-reversal genes activated by GHK in genome-wide expression studies.
Age-related decline
Reduction in plasma GHK concentration from age 20 to 60 — a key aging biomarker.
Topical concentration
GHK concentration range used in skin care formulations with clinical evidence for collagen effects.
Primary Applications
GHK Protocol Overview
Note: GHK-Cu (copper-chelated form) is preferred for skin applications. GHK alone is used for systemic protocols. Both are research compounds. Track all skin, energy, and biomarker responses in the Shotlee app.
Guide FAQs
GHK (glycyl-L-histidyl-L-lysine) is the base tripeptide before copper binding. Activates wound healing genes, collagen synthesis.
Yes. Shotlee supports tracking Ghk Peptide doses, side effects, and health metrics. It is free.
Track Your Ghk Peptide Protocol in Shotlee
Free dose logging, side effect tracking, and health metric monitoring for your complete protocol.
📚References & sources
Latest on Ghk Peptide
Peptides for Hair Loss: A Derm-Approved Ingredient for Thicker Hair
Discover how peptides, a common skincare ingredient, are making waves in hair loss treatment. This article delves into the science behind peptides and their potential to promote a healthier scalp and fuller-looking hair.
9 min read
Anandita Sundar's 7-Year Weight Loss Journey and Body Shaming
Anandita Sundar opens up about her seven-year weight loss journey, highlighting the profound impact of body shaming on mental health and her commitment to prioritizing well-being over societal expectations.
7 min read
Plus-Size Swimsuit Model on Inclusivity Amidst GLP-1 Medications
Plus-size model Hunter McGrady shares her concerns about a perceived decline in fashion inclusivity, particularly in the context of the growing popularity of GLP-1 weight loss medications.
7 min read